Atossa Therapeutics, Inc. Common Stock (ATOS)
Atossa Therapeutics, Inc. (ATOS) is a biotechnology company focused on developing targeted treatments for breast cancer, hormone-related issues, and other serious medical conditions. The company is particularly known for its research into novel therapies involving breast health and hormone modulation, aiming to address unmet medical needs through innovative drug delivery methods and clinical development efforts.
Company News
Atossa Therapeutics' CEO Dr. Steven Quay will participate in a fireside chat at the 27th Annual H.C. Wainwright Global Investment Conference, discussing clinical progress of their lead product (Z)-endoxifen, a potential breast cancer treatment and prevention therapy.
Atossa Therapeutics, a clinical-stage biopharmaceutical company, announced that its Vice President of Investor and Public Relations will participate in a virtual fireside chat at the 2024 Maxim Healthcare Virtual Summit.
Here is how Alvotech (ALVO) and Atossa Genetics Inc. (ATOS) have performed compared to their sector so far this year.
Penny stocks under $3 to watch this week. The post Best Penny Stocks To Buy? 4 Stocks Under $3 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Investors want to know if this clinical-stage cancer drug developer can keep putting up big gains.